Open Access Green as soon as Postprint is submitted to ZB.
Reactive oxygen species-scavenging nanosystems in the treatment of diabetic wounds.
Adv. Healthc. Mater. 12:e2300779 (2023)
Diabetic wounds are characterized by drug-resistant bacterial infections, biofilm formation, impaired angiogenesis and perfusion, and oxidative damage to the microenvironment. Given their complex nature, diabetic wounds remain a major challenge in clinical practice. Reactive oxygen species (ROS), which have been shown to trigger hyperinflammation and excessive cellular apoptosis, play a pivotal role in the pathogenesis of diabetic wounds. ROS-scavenging nanosystems have recently emerged as smart and multifunctional nanomedicines with broad synergistic applicability. The documented anti-inflammatory and pro-angiogenic ability of ROS-scavenging treatments predestines these nanosystems as promising options for the treatment of diabetic wounds. Yet, in this context, the therapeutic applicability and efficacy of ROS-scavenging nanosystems remain to be elucidated. Herein, the role of ROS in diabetic wounds is deciphered, and the properties and strengths of nanosystems with ROS-scavenging capacity for the treatment of diabetic wounds are summarized. In addition, the current challenges of such nanosystems and their potential future directions are discussed through a clinical-translational lens.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Biomedical Nanosystems ; Diabetic Wounds ; Nanomedicine ; Reactive Oxygen Species ; Treatment Mechanisms; Rheumatoid-arthritis; Cells; Microenvironment; Hydrogel; Exosomes; Ros; Nanoparticles; Angiogenesis; Inflammation; Expression
ISSN (print) / ISBN
2192-2640
e-ISSN
2192-2659
Journal
Advanced healthcare materials
Quellenangaben
Volume: 12,
Issue: 25,
Article Number: e2300779
Publisher
Wiley
Publishing Place
Weinheim
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Regenerative Biology (IRBM)
Grants
European Foundation for the Study of Diabetes